Skip to main content
FinSpry Logo
FinSpry
LUCD logo
LUCD
(NASDAQ)
Lucid Diagnostics Inc.
$1.00-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Lucid Diagnostics (LUCD) Stock Price & Financial Analysis

Lucid Diagnostics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.90 - $1.02
52-Week High$1.70
52-Week Low$0.95
Open$0.91
Volume1.46M
Average Volume (3M)958.30K
Market Cap154.04M
Shares Outstanding162.66M
Price to Sales (P/S)32.73
Price to Book (P/B)14.09
EV/EBITDA-568.94
Revenue (TTM)4.71M
Net Income (TTM)-67.12M
Free Cash Flow (TTM)-46.68M
EPS (TTM)$-0.61
Profit Margin-1426.26%
Operating Margin-1054.84%
Return on Equity (ROE)-613.75%
Debt to Equity2281.63
50-Day MA$1.22
200-Day MA$1.16
52-Week Change-7.27%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Lucid Diagnostics

What is the current stock price for LUCD?

As of the latest trading session, LUCD stock trades at $1.00. The 52-week range is $0.95–$1.70, with a day range of $0.90–$1.02.

What is the P/E ratio for LUCD?

The P/E ratio (Price-to-Earnings) for LUCD is shown in the Key Statistics section. This valuation metric helps compare Lucid Diagnostics Inc. to industry peers.

Does LUCD pay dividends?

Lucid Diagnostics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for LUCD?

Based on 3 analysts, the consensus for LUCD is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of LUCD?

Lucid Diagnostics's market capitalization is $162.7M, classifying it as a micro-cap company. Lucid Diagnostics operates in the Healthcare sector within the Medical Devices industry.